[HTML][HTML] Efficacy of FOLFOXIRI plus bevacizumab in liver-limited metastatic colorectal cancer: a pooled analysis of clinical studies by Gruppo Oncologico del Nord …

…, C Granetto, L Ferrari, L Urbani, U Cillo, P Pilati… - European Journal of …, 2017 - Elsevier
Secondary resection is a chance of cure for a subgroup of metastatic colorectal cancer (mCRC)
patients with unresectable liver-limited disease. Medical treatment has a dual goal: to …

Tumor necrosis factor, cancer and anticancer therapy

S Mocellin, CR Rossi, P Pilati, D Nitti - Cytokine & growth factor reviews, 2005 - Elsevier
Tumor necrosis factor (TNF) is being utilized as an antineoplastic agent for the treatment of
patients with locally advanced solid tumors. However, its role in cancer therapy is debated. …

Gastrointestinal stromal tumors: from a surgical to a molecular approach

…, R Mencarelli, M Foletto, P Pilati… - … Journal of Cancer, 2003 - Wiley Online Library
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the
digestive tract. These tumors span a wide clinical spectrum from benign to malignant and have …

Quantitative real-time PCR: a powerful ally in cancer research

S Mocellin, CR Rossi, P Pilati, D Nitti… - Trends in molecular …, 2003 - cell.com
In this era of the Human Genome Project, quantitation of gene expression in tumor or host
cells is of paramount importance for investigating the gene patterns responsible for cancer …

Interferon alpha for the adjuvant treatment of cutaneous melanoma

…, MB Lens, S Pasquali, P Pilati… - … of systematic reviews, 2013 - cochranelibrary.com
Background Interferon alpha is the only agent approved for the postoperative adjuvant
treatment of high‐risk cutaneous melanoma. However, the survival advantage associated with …

Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?

S Mocellin, P Pilati, M Lise, D Nitti - Journal of Clinical Oncology, 2007 - ascopubs.org
Purpose The treatment of unresectable liver-confined metastatic disease from colorectal
cancer (CRC) is a challenging issue. Although locoregional treatments such as hepatic arterial …

[HTML][HTML] Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis

…, L Perilli, E Rossi, G Esposito, M Rugge, P Pilati… - BMC genomics, 2013 - Springer
Background Qualitative alterations or abnormal expression of microRNAs (miRNAs) in
colon cancer have mainly been demonstrated in primary tumors. Poorly overlapping sets of …

Detection of molecular residual disease using personalized circulating tumor DNA assay in patients with colorectal cancer undergoing resection of metastases

…, M Schirripa, G Munari, U Cillo, P Pilati… - JCO Precision …, 2021 - ascopubs.org
PURPOSE More than 50% of patients with stage IV colorectal cancer (metastatic colorectal
cancer [mCRC]) relapse postresection. The efficacy of postoperative systemic treatment is …

Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic …

…, D Giannarelli, M Vaira, M Valle, P Pilati… - European Journal of …, 2011 - Elsevier
AIM: The present study was specifically designed to assess the major clinical and pathological
variables of patients with colorectal peritoneal carcinomatosis in order to investigate …

Pancreaticojejunostomy versus pancreaticogastrostomy reconstruction for the prevention of postoperative pancreatic fistula following pancreaticoduodenectomy

…, N Cheng, J Gong, Y Yuan, P Pilati… - Cochrane Database …, 2017 - cochranelibrary.com
Background Pancreatoduodenectomy is a surgical procedure used to treat diseases of the
pancreatic head and, less often, the duodenum. The most common disease treated is cancer, …